Sign inJoin waitlistJoin the waitlist

Taylor Ripley

Director of General Thoracic Surgery Research · Baylor College of Medicine

Credentials: · · · · · · ·

History

General Thoracic Surgery Research · Baylor College of Medicine
Present
Mesothelioma Treatment Center · Baylor College of Medicine
Present
Surgical Thoracic Oncology for VICC Division · Vanderbilt University Medical Center
Present

Thoracic Surgery
Memorial Sloan Kettering Cancer Center
2012–2014
Surgery
University of Colorado School of Medicine
2010–2012
Oncology
National Cancer Institute of the National Institute of Health
2009–2010
Baylor St. Luke's Medical Center
2004–2007
Vanderbilt University School of Medicine
2000–2004

Research

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Blood · 2009 · 1,148 citations
Postgastrectomy Syndromes and Nutritional Considerations Following Gastric Surgery
Review · Surgical Clinics of North America · 2017 · 93 citations
Polycomb repressor complex-2 is a novel target for mesothelioma therapy
Clinical Cancer Research · 2012 · 88 citations

Bryan Burt
26 papers
Jeremy Davis
20 papers
David Schrump
18 papers
SG
Shawn Groth
17 papers
Valerie Rusch
12 papers
Harvey Pass
10 papers
Jonathan Hernandez
9 papers
Andrea Wolf
8 papers
CK
Clinton Kemp
8 papers · 8 as a resident
IA
Itzhak Avital
8 papers
MR
Maheshwari Ramineni
8 papers
Hedy Kindler
7 papers

Grants

Novel Strategies to Improve Mesothelioma Therapy
National Cancer Institute · R01
PI · $1.6M · University of Hawaii at Manoa
2024–2029
Targeting the Mitochondria to Overcome Resistance to Immune Checkpoint Inhibition in Malignant Pleural Mesothelioma
National Cancer Institute · R37
Contact PI · $2M · Baylor College of Medicine
2024–2029
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
National Cancer Institute · R21
Contact PI · $407.7K · Baylor College of Medicine
2022–2024
Dynamic BH3 Profiling with Patient Derived Organoids of Esophageal Cancer and Mesothelioma Enable Precision-Based Targeting of the Mitochondrial Apoptotic Pathway
National Cancer Institute · R03
Contact PI · $160K · Baylor College of Medicine
2021–2023

Clinical trials

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Principal investigator · Recruiting · Phase 1, Phase 2
Baylor College of Medicine
2024–2028